Skip to main content
. 2016 Apr 18;5:11. doi: 10.1186/s40164-016-0040-7

Fig. 3.

Fig. 3

Kaplan–Meier estimates of progression-free survival from the start of first treatment to first documented disease progression or death, whichever occurred earlier, among patients who received pomalidomide plus low-dose dexamethasone in MM-011